EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
126 hedge funds and large institutions have $209M invested in Eagle Pharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 47 increasing their positions, 50 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
69% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 39
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
126
Holding in Top 10
–
Calls
$56K
Puts
$10K
Top Buyers
| 1 | +$5.75M | |
| 2 | +$4.67M | |
| 3 | +$3.21M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.99M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.33M |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$5.94M | |
| 3 | -$4.72M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.21M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.63M |